Source: Annual Congress 2001 - Apoptosis and lung injury
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. A. Bloor, E. Parker, R. A. Knight, M. A. Spiteri, J. T. Allen (Stoke-on-Trent, United Kingdom). Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis. Eur Respir J 2001; 16: Suppl. 31, 2476

Member's Comments

No comment yet.

Related content which might interest you: Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003 Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity Source: Eur Respir J 2003; 21: 842-847 Year: 2003 HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Epidermal growth factor in paediatric bronchoalveolar lavage fluid Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004 Enhanced expression of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-6 in bronchoalveolar lavage cells from patients with sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer. Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Increased vascular endothelial growth factor in acute eosinophilic pneumonia Source: Eur Respir J 2003; 21: 774-778 Year: 2003 Levels of tumour necrosis factor and interferon in bronchoalveolar lavage fluid and blood serum in children with chronic bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 530s Year: 2001 Expression of insulin-growth factor-I (IGF-I) in alveolar lymphocytes (AL) in interstitial lung diseases (ILD). Potential functions of AL-derived IGF Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005 Transforming growth factor beta in serum and bronchoalveolar lavage of COPD patients Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007 Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Increased myeloid dendritic cells in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis Source: Eur Respir J 2003 Dec 01;22(6):895-899 Year: 2003 Decrease of vascular endothelial growth factor in macrophages from long-term smokers Source: Eur Respir J 2005; 25: 626-633 Year: 2005 Alveolar lipoproteinosis syndromes Source: Eur Respir Mon 2011; 54: 171-186 Year: 2011